polyrizon-biotech.com (PLRZ) Quarterly EPS earnings growth
The quarterly EPS trend demonstrates the potential of Polyrizon Ltd (PLRZ) and its Trap and Protect technology, which creates a barrier against viruses and allergens. However, the speculative nature of early-stage development and a liquidity deficit create a risk of capital dilution, with the current parameter equal to -7.00. A critical dependence on third-party CROs and a lack of in-house capacity leave the business entirely reliant on external outsourcing.
%20Year-over-year%20earnings%20per%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_PLRZ_-_Polyrizon-Ltd_-_Year-over-year-earnings-per-share-growth-for-the-last-12-months "PLRZ: Polyrizon Year-over-year net earnings per share growth for the last 12 months 10/30/2024 - 11/10/2026 | 👁️GURU.Markets👁️")
Polyrizon Ltd (PLRZ) - metric breakdowns and financial figures
- share price and expert price forecast:
- market capitalization details:
- balance sheet net asset value indicators:
- debt and solvency information:
Total Debt to Capital Polyrizon Ltd|PLRZ - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital polyrizon-biotech.com|PLRZ - Company Aggregate Debts|Debt to Book Capitalization Ratio Polyrizon Ltd.|PLRZ - Company Long-Term Loans and Borrowings|Company Short-Term Debt Polyrizon|Quick Ratio polyrizon-biotech.com
- earnings and valuation multiples information:
PLRZ - Net Profit|Expected Profit Polyrizon Ltd|PLRZ - Market Cap to Net Income|Future Price to Earnings polyrizon-biotech.com|PLRZ - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Polyrizon Ltd.|PLRZ - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Polyrizon|PLRZ - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months polyrizon-biotech.com|PLRZ - Earnings per share increase in current year|Earnings growth forecast for next year Polyrizon Ltd
Initial company analysis:Polyrizon Ltd
This indicator measures the dynamics of net profit per share by calculating the percentage deviation of the current quarterly EPS from the same period last year to assess business scaling rates. By analyzing the quarterly EPS growth rate, a Polyrizon Ltd (PLRZ) investor can promptly track the impact of geopolitical instability in Israel on bio-laboratory profitability and the resilience of component supply chains.
Who Polyrizon Ltd competes with
VRTX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alnylam Pharmaceuticals, Inc. (ALNY)|INSM (Insmed Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months UTHR (United Therapeutics Inc.)|Year-over-year net earnings per share growth for the last 12 months BMRN (BioMarin Pharmaceutical)|BBIO (bridgebio.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months BGM Group BGM|COGT (Cogent Biosciences Inc) - Year-over-year net earnings per share trend for the last twelve months|Xeris Biopharma Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KROS (Keros Corp)|ARCT: Quarterly EPS earnings growth|etonpharma.com (ETON) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Kamada|FULC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Abeona Therapeutics (ABEO)|Year-over-year net earnings per share growth for the last 12 months mereobiopharma.com MREO|Quarterly EPS earnings growth PLX (Protalix BioTherapeutics)|Quarterly EPS earnings growth Pliant Therapeutics Inc PLRX|APLT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months RNTX|gelteq.com (GELS) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Aytu BioPharma (AYTU)|Year-over-year earnings per share growth for the last twelve months Chemomab Therapeutics Ltd|Year-over-year earnings per share growth for the last twelve months SRXH|Year-over-year net earnings per share growth for the last 12 months AEZS (Aeterna Zentaris)|CYTH - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Inozyme Pharma INZY|Year-over-year earnings per one share growth for the last 12 months RPHM|COSCIENS Biopharma Inc. - Quarterly EPS earnings growth
